Barclays PLC Puma Biotechnology, Inc. Put Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $95,542 - $194,902	-4,600 Reduced 47.92%	5,000 $194,000
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $188,658 - $438,980	9,400 Added 4700.0%	9,600 $195,000
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $120,750 - $170,625	-2,500 Reduced 92.59%	200 $12,000
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $3.4 Million - $5.65 Million	-56,900 Reduced 95.47%	2,700 $184,000
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $2.79 Million - $3.93 Million	29,700 Added 99.33%	59,600 $5.89 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $2.15 Million - $3.58 Million	29,900	29,900 $3.58 Million

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $139M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.